Otsuka Pharmaceutical enters $1.5 billion multi-target partnership with ShapeTX; Novartis’ research and development hub has a new name; Eli Lilly’s Mounjaro receives approval from the U.K.’s cost-effectiveness watchdog.
Five things for pharma marketers to know: Friday, September 8, 2023
Nimbus Therapeutics raises $210 million; Johnson & Johnson stops a Phase 3 study evaluating its pulmonary arterial hypertension drug; Pfizer and Valneva announce that a Phase 2 study for its VLA15 Lyme disease vaccine candidate showed a “strong immune response.”
Five things for pharma marketers to know: Thursday, September 7, 2023
Moderna’s updated COVID-19 vaccine effective against BA.2.86 subvariant; Astellas withdraws lawsuit against the Biden administration over Medicare price negotiation powers; Johnson & Johnson announces its combination drug helped increase the duration of no progress in a type of non small-cell lung cancer in patients.
Mississippi’s cervical cancer deaths indicate broader health care problems
Mississippi had the nation’s second-highest age-adjusted cervical cancer mortality rate, 3.4 deaths per 100,000 women and girls annually from 2016 through 2020
Five things for pharma marketers to know: Wednesday, September 6, 2023
How Novartis’ CEO learned from his mistakes; Olema Pharmaceuticals reaches $180 million financing deal; Tonix Pharmaceuticals said topline results from its Phase 2 proof-of-concept study of TNX-102 misses primary endpoint.
Five things for pharma marketers to know: Tuesday, September 5, 2023
Some people pay more than $10,000 a year out-of-pocket for Ozempic and Mounjaro; Venture firms back startups that promise to use AI to help with drug discoveries; Sen. Jacky Rosen reaps windfall from investments in drugmakers that have jacked up prices.
Five things for pharma marketers to know: Friday, September 1, 2023
Gene-editing biotech Metagenomi is preparing to go public; In light of Hurricane Idalia’s landfall, the CDC reminds people of floodwater health risks; Eli Lilly CEO David Ricks donates $25,000 to a super PAC supporting former Vice President Mike Pence’s presidential bid.
Five things for pharma marketers to know: Thursday, August 31, 2023
Johnson & Johnson updates its 2023 financial guidance in the wake of Kenvue separation; The EMA says its human medicines committee recommended authorizing Pfizer’s updated COVID-19 vaccine; Walmart asks some of its 16,000 pharmacists across the U.S. to voluntarily take pay cuts.
AmerisourceBergen no more: Company changes name to Cencora